1. Home
  2. EPOW vs VNRX Comparison

EPOW vs VNRX Comparison

Compare EPOW & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EPOW

Sunrise New Energy Co. Ltd

HOLD

Current Price

$0.84

Market Cap

29.9M

ML Signal

HOLD

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.16

Market Cap

31.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPOW
VNRX
Founded
2014
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.9M
31.9M
IPO Year
2019
2012

Fundamental Metrics

Financial Performance
Metric
EPOW
VNRX
Price
$0.84
$0.16
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$2.00
AVG Volume (30 Days)
162.5K
16.0M
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
N/A
N/A
Revenue
N/A
$1,727,384.00
Revenue This Year
N/A
$479.89
Revenue Next Year
N/A
$536.25
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40.04
52 Week Low
$0.66
$0.17
52 Week High
$1.86
$0.94

Technical Indicators

Market Signals
Indicator
EPOW
VNRX
Relative Strength Index (RSI) 48.27 35.69
Support Level $0.74 N/A
Resistance Level $1.05 $0.32
Average True Range (ATR) 0.10 0.03
MACD 0.00 -0.00
Stochastic Oscillator 28.38 8.71

Price Performance

Historical Comparison
EPOW
VNRX

About EPOW Sunrise New Energy Co. Ltd

E Power Inc, through its subsidiaries, is engaged in the manufacturing and sale of graphite anode material for lithium-ion batteries. The company operates a plant in Guizhou Province, China, powered by electricity from renewable sources, which contributes to the plant's low production costs and reduced environmental impact in the production of graphite anode materials. Additionally, it also operates a knowledge sharing platform business.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: